What is the market import price of a box of regorafenib in 2025?
Regorafenib is an oral multi-target tyrosine kinase inhibitor mainly used to treat specific types of cancer, especially metastatic colorectal cancer, gastrointestinal stromal tumors and hepatocellular carcinoma. Its mechanism of action is to inhibit tumor cell proliferation, angiogenesis and related signaling pathways in the tumor microenvironment, thereby achieving the effect of inhibiting tumor growth and spread. Regorafenib improves the effectiveness of treatment by acting on multiple targets and may also reduce the occurrence of drug resistance.
In China, regorafenib has obtained marketing authorization and been included in the medical insurance directory, which provides patients with certain financial support and enables more patients to obtain this treatment option. According to the latest information, the domestic market price of regorafenib is approximately four to five thousand yuan. The specific price may vary depending on regions, hospitals, and medical insurance policies. Therefore, patients are advised to consult their local hospital pharmacy for accurate pricing and reimbursement information when purchasing.
In addition, regorafenib also has original drugs and generic drugs available in the international market. Original drugs are mainly manufactured in Turkey, and their prices are usually more than 1,000 yuan, while generic drugs come from countries such as Laos, India, and Bangladesh, and their prices range from a few hundred yuan to more than 1,000 yuan. These generic drugs have basically the same ingredients and similar efficacy as the original drugs, so they are undoubtedly a more attractive option for patients with limited economic conditions.
It needs to be emphasized that although the price of foreign generic drugs is lower, patients should still be cautious when choosing to use them, ensure that the sources of drugs are regular, and use them under the guidance of professional doctors to ensure efficacy and safety.
Reference materials:https://www.stivarga-us.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)